Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Estrogen Receptor Positive Breast Cancer × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 10 Breast Neoplasms 7 Prostatic Neoplasms 6 Colorectal Neoplasms 6 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Multiple Myeloma 3 Melanoma 3 Gastrointestinal Neoplasms 3 COVID-19 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumor 2 Recurrence 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Leukemia 2 Glioblastoma 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Adenocarcinoma of Lung 2 Urologic Diseases 1 Untreated Resectable Pancreatic Adenocarcinoma 1 Sarcoma, Clear Cell 1 Sarcoma 1 Respiratory Distress Syndrome 1 Resectable Localized Prostate Cancer 1

Interventions

Fulvestrant 2 vistusertib 1 capivasertib 1 Transurethral Resection of Bladder 1 Hydroxychloroquine 1 Everolimus 1 Estrogens 1 Estradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02414776 2017-09-27

ABC01

Western Regional Medical Center

Phase 1 Terminated

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡